NO942178D0 - 20-metylsubstituerte vitamin D-derivater - Google Patents

20-metylsubstituerte vitamin D-derivater

Info

Publication number: NO942178D0
Authority: NO; Norway
Prior art keywords: group; derivatives; methyl; carbon atoms; production
Prior art date: 1991-12-13

Application number

NO942178A

Other languages

English (en)

Other versions

NO305949B1 (no

NO942178L (no

Inventor

Gunter Neef

Andreas Steinmeyer

Gerald Kirsch

Katica Schwarz

Ruth Thieroff-Ekerdt

Herbert Wiesinger

Martin Haberey

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-12-13

Filing date

1994-06-10

Publication date

1994-06-10

1994-06-10 Application filed by Schering Ag filed Critical Schering Ag

1994-06-10 Publication of NO942178L publication Critical patent/NO942178L/no

1994-06-10 Publication of NO942178D0 publication Critical patent/NO942178D0/no

1999-08-23 Publication of NO305949B1 publication Critical patent/NO305949B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Obesity (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Oncology (AREA)
Nutrition Science (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO942178A 1991-12-13 1994-06-10 20-metylsubstituerte vitamin D-derivater, farmasoeytiske preparater inneholdende disse, og anvendelse derav NO305949B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4141746A DE4141746A1 (de)	1991-12-13	1991-12-13	20-methyl-substituierte vitamin d-derivate
PCT/EP1992/002887 WO1993012081A1 (de)	1991-12-13	1992-12-14	20-methyl-substituierte vitamin d-derivate

Publications (3)

Publication Number	Publication Date
NO942178L NO942178L (no)	1994-06-10
NO942178D0 true NO942178D0 (no)	1994-06-10
NO305949B1 NO305949B1 (no)	1999-08-23

Family

ID=6447341

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO942178A NO305949B1 (no)	1991-12-13	1994-06-10	20-metylsubstituerte vitamin D-derivater, farmasoeytiske preparater inneholdende disse, og anvendelse derav

Country Status (24)

Country	Link
US (1)	US5446035A (no)
EP (1)	EP0637299B1 (no)
JP (1)	JP3280975B2 (no)
KR (1)	KR100271462B1 (no)
CN (1)	CN1035177C (no)
AT (1)	ATE138366T1 (no)
AU (1)	AU670585B2 (no)
CA (1)	CA2125476C (no)
CZ (1)	CZ286579B6 (no)
DE (2)	DE4141746A1 (no)
DK (1)	DK0637299T3 (no)
ES (1)	ES2089585T3 (no)
FI (1)	FI108226B (no)
GR (1)	GR3020097T3 (no)
HU (1)	HUT68263A (no)
IL (1)	IL104074A (no)
MX (1)	MX9207101A (no)
NO (1)	NO305949B1 (no)
NZ (1)	NZ246052A (no)
PL (1)	PL171403B1 (no)
SK (1)	SK280450B6 (no)
TW (1)	TW275060B (no)
WO (1)	WO1993012081A1 (no)
ZA (1)	ZA929650B (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4220757A1 (de) *	1992-06-24	1994-01-05	Schering Ag	Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
GB9220272D0 (en) *	1992-09-25	1992-11-11	Leo Pharm Prod Ltd	Chemical compounds
IL107185A (en) *	1992-10-06	1998-02-22	Schering Ag	Vitamin d, 25-carboxylic acid derivatives and pharmaceutical compositions containing the same
US6407082B1 (en) *	1996-09-13	2002-06-18	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of a vitamin D compound
US20040167106A1 (en) *	1993-06-04	2004-08-26	Rodriguez Gustavo C.	Prevention of ovarian cancer by administration of a Vitamin D compound
GB9315253D0 (en) *	1993-07-23	1993-09-08	Res Inst Medicine Chem	Chemical compounds
US5428029A (en) *	1993-11-24	1995-06-27	Hoffmann-La Roche Inc.	Vitamin D3 fluorinated analogs
US5981597A (en) *	1995-02-13	1999-11-09	Trustees Of The University Of Pennsylvania	Differentiating agents for the treatment of inflammatory intestinal diseases
AU2250097A (en) *	1996-02-13	1997-09-02	G.D. Searle & Co.	Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist
DE19619036A1 (de)	1996-04-30	1997-11-13	Schering Ag	Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
SG70010A1 (en) *	1996-05-23	2000-01-25	Hoffmann La Roche	Fluorinated vitamin d3 analogs
US6034074A (en) *	1996-09-13	2000-03-07	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of a Vitamin D compound
US6765002B2 (en)	2000-03-21	2004-07-20	Gustavo Rodriguez	Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6511970B1 (en)	1996-09-13	2003-01-28	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6028064A (en)	1996-09-13	2000-02-22	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of progestin products
JP4219553B2 (ja)	1997-09-08	2009-02-04	エフ．ホフマン−ラロシュアーゲー	１，３−ジヒドロキシ−２０，２０−ジアルキル−ビタミンｄ３類似体
EP2340840B1 (en)	1998-03-27	2012-08-29	Oregon Health Sciences University	Pulse dose Vitamin D drug for the treatment of hyperproliferative skin diseases
US6443856B1 (en)	1999-11-01	2002-09-03	Callaway Golf Company	Contoured scorelines for the face of a golf club
US20030188756A1 (en) *	2002-08-19	2003-10-09	Cantorna Margherita T	Treatment of inflammatory bowel disease with vitamin d compounds
US6989377B2 (en)	1999-12-21	2006-01-24	Wisconsin Alumni Research Foundation	Treating vitamin D responsive diseases
US6358939B1 (en)	1999-12-21	2002-03-19	Northern Lights Pharmaceuticals, Llc	Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
WO2006120682A2 (en) *	2005-05-10	2006-11-16	Dermipsor Ltd.	Compositions and methods for treating hyperproliferative epidermal diseases
US20010044431A1 (en) *	2000-03-21	2001-11-22	Rodriguez Gustavo C.	Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
EP1314427A4 (en) *	2000-08-17	2006-05-03	Chugai Pharmaceutical Co Ltd	THERAPEUTIC AGENT FOR THE TREATMENT OF OSTEOPOROSIS
TWI329105B (en) *	2002-02-01	2010-08-21	Rigel Pharmaceuticals Inc	2,4-pyrimidinediamine compounds and their uses
ES2421139T3 (es)	2003-07-30	2013-08-29	Rigel Pharmaceuticals, Inc.	Compuestos de 2,4-pirimidindiamina para su uso en el tratamiento o la prevención de enfermedades autoinmunitarias
CA2608021A1 (en) *	2005-05-10	2006-11-16	Dermipsor Ltd.	Compositions and methods for skin care
JP2008543855A (ja)	2005-06-13	2008-12-04	ライジェルファーマシューティカルズ，インコーポレイテッド	変形性骨疾患を処置するための方法および組成物
EP1734251B1 (en) *	2005-06-17	2007-01-24	MAGNETI MARELLI POWERTRAIN S.p.A.	Fuel injector
WO2008023278A2 (en) *	2006-04-10	2008-02-28	Wisconsin Alumni Research Foundation	1alpha-hydroxy-2- (3 ' -hydroxypropylidene) -19-n0r- vitamin d compounds with a 1,1-dimethylpropyl side chain
AU2007287099A1 (en)	2006-08-25	2008-02-28	Cougar Biotechnology, Inc.	Methods for treating cancer comprising the administration of a vitamin D compound and an additional therapeutic agent, and compositions containing the same
US20080051375A1 (en) *	2006-08-25	2008-02-28	Auerbach Alan H	Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same
US20080051380A1 (en)	2006-08-25	2008-02-28	Auerbach Alan H	Methods and compositions for treating cancer
US20090124587A1 (en) *	2007-07-12	2009-05-14	Auerbach Alan H	METHODS FOR TREATING CANCER USING 17alpha-HYDROXYLASE/C17,20-LYASE INHIBITORS
CA2750659C (en)	2009-01-27	2017-11-21	Berg Biosystems, Llc	Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
EA201270226A1 (ru)	2009-08-14	2012-09-28	БЕРГ БАЙОСИСТЕМЗ, ЭлЭлСи	Витамин d3 и его аналогии для лечения алопеции
US20190183908A1 (en)	2016-05-13	2019-06-20	Case Western Reserve University	Autophagy activators for treating or preventing skin injury
RS66574B1 (sr)	2016-07-29	2025-03-31	Janssen Pharmaceutica Nv	Niraparib za upotrebu u postupku lečenja raka prostate
US10548908B2 (en)	2016-09-15	2020-02-04	Nostopharma, LLC	Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification
US11903952B2 (en)	2020-05-27	2024-02-20	Northwestern University	Vitamin D as an immune modulator to prevent immune-related complication from COVID-19 infection

1991
- 1991-12-13 DE DE4141746A patent/DE4141746A1/de not_active Withdrawn
1992
- 1992-12-08 MX MX9207101A patent/MX9207101A/es not_active IP Right Cessation
- 1992-12-11 ZA ZA929650A patent/ZA929650B/xx unknown
- 1992-12-12 CN CN92114249A patent/CN1035177C/zh not_active Expired - Fee Related
- 1992-12-13 IL IL104074A patent/IL104074A/en not_active IP Right Cessation
- 1992-12-14 EP EP92924724A patent/EP0637299B1/de not_active Expired - Lifetime
- 1992-12-14 KR KR1019940702001A patent/KR100271462B1/ko not_active Expired - Fee Related
- 1992-12-14 ES ES92924724T patent/ES2089585T3/es not_active Expired - Lifetime
- 1992-12-14 DE DE59206393T patent/DE59206393D1/de not_active Expired - Lifetime
- 1992-12-14 SK SK661-94A patent/SK280450B6/sk unknown
- 1992-12-14 WO PCT/EP1992/002887 patent/WO1993012081A1/de not_active Ceased
- 1992-12-14 PL PL92304142A patent/PL171403B1/pl not_active IP Right Cessation
- 1992-12-14 CZ CZ19941416A patent/CZ286579B6/cs not_active IP Right Cessation
- 1992-12-14 DK DK92924724.5T patent/DK0637299T3/da active
- 1992-12-14 AU AU40356/93A patent/AU670585B2/en not_active Ceased
- 1992-12-14 NZ NZ246052A patent/NZ246052A/xx unknown
- 1992-12-14 JP JP51062193A patent/JP3280975B2/ja not_active Expired - Fee Related
- 1992-12-14 HU HU9401456A patent/HUT68263A/hu unknown
- 1992-12-14 CA CA002125476A patent/CA2125476C/en not_active Expired - Fee Related
- 1992-12-14 AT AT92924724T patent/ATE138366T1/de not_active IP Right Cessation
1993
- 1993-01-13 TW TW082100181A patent/TW275060B/zh active
1994
- 1994-06-10 FI FI942766A patent/FI108226B/fi not_active IP Right Cessation
- 1994-06-10 NO NO942178A patent/NO305949B1/no unknown
- 1994-09-16 US US08/307,081 patent/US5446035A/en not_active Expired - Fee Related
1996
- 1996-05-30 GR GR960401459T patent/GR3020097T3/el unknown

Also Published As

Publication number	Publication date
NO305949B1 (no)	1999-08-23
GR3020097T3 (en)	1996-08-31
US5446035A (en)	1995-08-29
EP0637299B1 (de)	1996-05-22
AU4035693A (en)	1993-07-19
DE4141746A1 (de)	1993-06-17
NO942178L (no)	1994-06-10
CN1035177C (zh)	1997-06-18
KR940703806A (ko)	1994-12-12
SK280450B6 (sk)	2000-02-14
PL171403B1 (pl)	1997-04-30
IL104074A0 (en)	1993-05-13
IL104074A (en)	1998-01-04
DK0637299T3 (da)	1996-09-30
ATE138366T1 (de)	1996-06-15
HU9401456D0 (en)	1994-08-29
SK66194A3 (en)	1995-02-08
KR100271462B1 (ko)	2000-11-15
FI942766A7 (fi)	1994-06-10
ZA929650B (en)	1993-06-09
FI108226B (fi)	2001-12-14
CA2125476A1 (en)	1993-06-24
MX9207101A (es)	1993-08-01
WO1993012081A1 (de)	1993-06-24
TW275060B (no)	1996-05-01
CZ286579B6 (cs)	2000-05-17
HUT68263A (en)	1995-06-28
JP3280975B2 (ja)	2002-05-13
ES2089585T3 (es)	1996-10-01
JPH07505132A (ja)	1995-06-08
AU670585B2 (en)	1996-07-25
CZ141694A3 (en)	1995-01-18
DE59206393D1 (de)	1996-06-27
FI942766A0 (fi)	1994-06-10
CA2125476C (en)	2003-02-11
EP0637299A1 (de)	1995-02-08
CN1073677A (zh)	1993-06-30
NZ246052A (en)	1995-07-26

Publication	Publication Date	Title
ATE138366T1 (de)	1996-06-15	20-methyl-substituierte vitamin d-derivate
ES8802017A1 (es)	1988-03-16	Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
DK142987A (da)	1987-03-20	Hidtil ukendte vitamin d-analoger
NO951813D0 (no)	1995-05-09	Bicyklisk heterocyklisk sulfonamid og sulfonester-derivater
ES2117281T3 (es)	1998-08-01	Nuevos analogos de la vitamina d.
ES458264A1 (es)	1978-07-16	Procedimiento para la preparacion de nuevos compuestos ana- logos a prostaglandinas.
ATE45347T1 (de)	1989-08-15	Vitamin d3-derivate.
ES459050A1 (es)	1978-11-01	Un procedimiento para la preparacion de nuevos derivados de acido prostanoico.
MX9204858A (es)	1993-05-01	Mejoras en derivados de 2-(piperazinoalquil)indol condensados en posiciones 1,7, asi como un procedimiento y productos intermedios para su preparacion y medicamentos que contienen estos compuestos.
DE3575715D1 (de)	1990-03-08	Adamantanamin-derivate, verfahren zur herstellung und diese enthaltende heilmittel.
ES449963A2 (es)	1977-10-01	Procedimiento de preparacion de derivados piridinicos.
RO92856A (ro)	1987-11-30	Procedeu pentru prepararea unor derivati de 6,16-dimetilcorticoide
ES473441A1 (es)	1979-05-01	Procedimiento para la preparacion de nuevos derivados de 5,-11-dihidro-6h-pirido (2,3-b)(1,4-benzodiazepin-6-ona).
ES2072765T3 (es)	1995-07-16	Procedimiento para la obtencion de 5,6-dihidroxi-indolinas.
ES2155948T3 (es)	2001-06-01	20-oxopregna-derivados 17-cadena lateral alquinilica de la vitamina d, metodos para su produccion y composiciones farmaceuticas de los mismos.
ZA945754B (en)	1995-03-15	15,15-dialkyl-substituted derivatives of estradiol
AU563426B2 (en)	1987-07-09	3-alkoxy-2(n-pyrrolidino)-n-pyridyl-n-furyl (or thienyl) methyl propylamines
ES8608492A1 (es)	1986-06-16	Procedimiento para la obtencion de derivados de 3-(ureidociclohexilamino) propan-1, 2-diol
TW252976B (no)	1995-08-01
HUT35658A (en)	1985-07-29	Process for producing 7-oxo-prostacycline derivatives of selective biological activity
DK0746556T3 (da)	2002-12-16	Tricycliske forbindelser med affinitet for 5-HT1A-receptoren
ES2059702T3 (es)	1994-11-16	Politioureas, procedimiento para su fabricacion y empleo de estas politioureas para evitar o reducir la formacion de costras en reactores.
GB1416929A (en)	1975-12-10	Fluoranthene derivatives
ES2085544T3 (es)	1996-06-01	Procedimiento para la fabricacion de 8-n,n-dialquilaminotriciclo-(5.2.1.02,6)decano.
JPS5229251A (en)	1977-03-04	Support e1uipment for measurement instrument